• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因和自体骨髓移植受者血清免疫球蛋白水平与特异性抗体水平的关系

Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.

作者信息

Hammarström V, Pauksen K, Svensson H, Lönnqvist B, Simonsson B, Ringdén O, Ljungman P

机构信息

Department of Hematology, Karolinska Institute, Huddinge University Hospital, Sweden.

出版信息

Transplantation. 2000 Apr 27;69(8):1582-6. doi: 10.1097/00007890-200004270-00011.

DOI:10.1097/00007890-200004270-00011
PMID:10836366
Abstract

The aim of this study was to investigate the correlation of total levels of immunoglobulins to levels of specific antibodies after allogeneic and autologous bone marrow transplantation. Autologous transplant patients had normal levels of IgA and IgG antibodies already at 6 months after transplantation. In allogeneic transplanted patients without chronic graft versus host disease the immunological recovery was slower. The IgA and IgG levels were at the limit for deficiency at 6 months after transplantation. In allogeneic transplant patients with chronic chronic graft versus host disease the immunological recovery was delayed further. The total IgG levels were low at 12 months after transplantation and the IgG subclass pattern did not normalize until 24 months after transplantation. IgA levels remained low at 24 months after transplantation in all allogeneic transplanted patients with chronic chronic graft versus host disease. Protective levels of specific antibodies against tetanus and pneumococci decreased during the first year after transplantation regardless of the total immunoglobulin levels, regardless of the donors immunity. Pneumococcal antibodies decreased only in allogeneic transplanted patients, although autologous transplant patients retained pretransplant immunity against pneumococci. There was no difference in levels of specific antibodies between patients with and without chronic chronic graft versus host disease at 12 months after transplantation. There was no correlation between total immunoglobulin levels to levels of specific antibodies against tetanus and pneumococci after transplantation in our study. Taken together, normalized immunoglobulin levels do not predict normalization of levels of specific antibodies against tetanus and pneumococci after transplantation.

摘要

本研究旨在调查异基因和自体骨髓移植后免疫球蛋白总水平与特异性抗体水平之间的相关性。自体移植患者在移植后6个月时IgA和IgG抗体水平已恢复正常。在没有慢性移植物抗宿主病的异基因移植患者中,免疫恢复较慢。移植后6个月时,IgA和IgG水平处于缺乏的临界值。在患有慢性移植物抗宿主病的异基因移植患者中,免疫恢复进一步延迟。移植后12个月时总IgG水平较低,IgG亚类模式直到移植后24个月才恢复正常。在所有患有慢性移植物抗宿主病的异基因移植患者中,移植后24个月时IgA水平仍较低。无论总免疫球蛋白水平如何,无论供体免疫状态如何,移植后第一年针对破伤风和肺炎球菌的特异性抗体保护水平均下降。肺炎球菌抗体仅在异基因移植患者中下降,尽管自体移植患者保留了移植前对肺炎球菌的免疫力。移植后12个月时,患有和未患有慢性移植物抗宿主病的患者之间特异性抗体水平没有差异。在我们的研究中,移植后总免疫球蛋白水平与针对破伤风和肺炎球菌的特异性抗体水平之间没有相关性。综上所述,免疫球蛋白水平正常并不能预测移植后针对破伤风和肺炎球菌的特异性抗体水平是否正常。

相似文献

1
Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients.异基因和自体骨髓移植受者血清免疫球蛋白水平与特异性抗体水平的关系
Transplantation. 2000 Apr 27;69(8):1582-6. doi: 10.1097/00007890-200004270-00011.
2
Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction.骨髓移植患者的肺炎球菌免疫及对肺炎球菌疫苗免疫接种的反应:移植物抗宿主反应的影响
Support Care Cancer. 1993 Jul;1(4):195-9. doi: 10.1007/BF00366446.
3
Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.自体外周血干细胞移植受者和骨髓移植受者在移植后两年内接种疫苗后的抗体反应相似。
Bone Marrow Transplant. 2001 Oct;28(8):775-81. doi: 10.1038/sj.bmt.1703239.
4
Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.接受同种异体骨髓移植的患者在接种肺炎球菌疫苗前后的肺炎球菌抗体滴度。
J Infect Dis. 1986 Oct;154(4):590-6. doi: 10.1093/infdis/154.4.590.
5
[Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].[同种异体和自体骨髓移植及加强免疫后破伤风类毒素、白喉类毒素、麻疹病毒、脊髓灰质炎病毒和肺炎球菌疫苗抗体的动力学。1:同种异体和自体骨髓移植后破伤风类毒素疫苗抗体的动力学]
Kinderarztl Prax. 1992 Jun;60(4-5):124-30.
6
Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.同种异体和自体骨髓移植受者的唾液和血清免疫球蛋白
Bone Marrow Transplant. 1994 Aug;14(2):229-34.
7
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.异基因或同基因骨髓移植后存活20至30年患者的免疫情况。
Blood. 2001 Dec 15;98(13):3505-12. doi: 10.1182/blood.v98.13.3505.
8
[The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus].[同种异体和自体骨髓移植及再接种后针对破伤风类毒素、白喉类毒素、麻疹病毒、脊髓灰质炎病毒和肺炎球菌的疫苗抗体动力学。3:同种异体和自体骨髓移植及白喉和破伤风联合再接种后针对破伤风类毒素和白喉类毒素的疫苗抗体动力学]
Kinderarztl Prax. 1992 Nov;60(8):230-8.
9
Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation.骨髓移植后特定类别和亚类的肺炎球菌抗体水平及对免疫接种的反应。
Clin Exp Immunol. 1992 Jun;88(3):512-9. doi: 10.1111/j.1365-2249.1992.tb06480.x.
10
Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation.接受骨髓移植的儿童对肺炎球菌疫苗的抗体反应。
J Clin Immunol. 1995 May;15(3):137-44. doi: 10.1007/BF01543105.

引用本文的文献

1
N-Glycosylation Alteration of Serum and Salivary Immunoglobulin a Is a Possible Biomarker in Oral Mucositis.血清和唾液免疫球蛋白A的N-糖基化改变可能是口腔黏膜炎的生物标志物。
J Clin Med. 2020 Jun 5;9(6):1747. doi: 10.3390/jcm9061747.
2
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma.多发性骨髓瘤患者异基因干细胞移植后的长期生存和多克隆免疫球蛋白重建。
Ann Hematol. 2020 Aug;99(8):1907-1915. doi: 10.1007/s00277-020-04068-5. Epub 2020 May 22.
3
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.
儿童造血干细胞移植后 B 细胞重建及影响因素。
Front Immunol. 2019 Apr 12;10:782. doi: 10.3389/fimmu.2019.00782. eCollection 2019.
4
Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.造血干细胞移植后的感染并发症:韩国的现状与未来展望
Korean J Intern Med. 2018 Mar;33(2):256-276. doi: 10.3904/kjim.2018.036. Epub 2018 Feb 27.
5
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).严重医源性淋巴细胞减少症(为治疗自身免疫性疾病而诱发)的恢复情况及后果。
Clin Immunol. 2004 Dec;113(3):285-98. doi: 10.1016/j.clim.2004.07.006.
6
Pneumococcal sepsis due to functional hyposplenism in a bone marrow transplant patient.一名骨髓移植患者因功能性脾功能减退导致肺炎球菌败血症。
Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):212-4. doi: 10.1007/s10096-003-1091-3. Epub 2004 Feb 19.
7
High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.霍奇金病患者的大剂量治疗:使用选定的CD34(+)细胞与未处理的外周血祖细胞一样安全。
Bone Marrow Transplant. 2001 Nov;28(9):849-57. doi: 10.1038/sj.bmt.1703244.
8
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).接受异基因骨髓移植(BMT)治疗的患者中寡克隆血清IgM库的长期持续性。
Clin Exp Immunol. 2000 Jan;119(1):240-9. doi: 10.1046/j.1365-2249.2000.01118.x.